ASX:BOT

Botanix Pharmaceuticals Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.63 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Botanix Pharmaceuticals (ASX:BOT) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying BOT stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Botanix Pharmaceuticals, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Botanix Pharmaceuticals (ASX:BOT) and (CHV) (CNSX:CHV) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings.

Valuation and Earnings

This table compares Botanix Pharmaceuticals and (CHV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A
(CHV)N/AN/AN/AN/AN/A

(CHV) has lower revenue, but higher earnings than Botanix Pharmaceuticals.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Botanix Pharmaceuticals and (CHV), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Botanix Pharmaceuticals0000N/A
(CHV)0000N/A

Profitability

This table compares Botanix Pharmaceuticals and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Botanix PharmaceuticalsN/AN/AN/A
(CHV)N/AN/AN/A

Summary

Botanix Pharmaceuticals beats (CHV) on 1 of the 1 factors compared between the two stocks.

Botanix Pharmaceuticals (ASX:BOT) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership and earnings.

Profitability

This table compares Botanix Pharmaceuticals and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Botanix PharmaceuticalsN/AN/AN/A
(DDXS)N/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Botanix Pharmaceuticals and (DDXS), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Botanix Pharmaceuticals0000N/A
(DDXS)0000N/A

Valuation and Earnings

This table compares Botanix Pharmaceuticals and (DDXS)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than Botanix Pharmaceuticals.

Summary

Botanix Pharmaceuticals beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Botanix Pharmaceuticals (ASX:BOT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (PREV) and Botanix Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Botanix PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (PREV) and Botanix Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Botanix Pharmaceuticals0000N/A

Valuation & Earnings

This table compares (PREV) and Botanix Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A

(PREV) has higher earnings, but lower revenue than Botanix Pharmaceuticals.

Summary

Botanix Pharmaceuticals beats (PREV) on 1 of the 1 factors compared between the two stocks.

(TNGN) (OTCMKTS:TNGN) and Botanix Pharmaceuticals (ASX:BOT) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (TNGN) and Botanix Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
Botanix PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (TNGN) and Botanix Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Botanix Pharmaceuticals0000N/A

Valuation & Earnings

This table compares (TNGN) and Botanix Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A

(TNGN) has higher earnings, but lower revenue than Botanix Pharmaceuticals.

Summary

Botanix Pharmaceuticals beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and Botanix Pharmaceuticals (ASX:BOT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares 138267 (COM.TO) and Botanix Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
Botanix PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 138267 (COM.TO) and Botanix Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
Botanix Pharmaceuticals0000N/A

Valuation & Earnings

This table compares 138267 (COM.TO) and Botanix Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A

138267 (COM.TO) has higher earnings, but lower revenue than Botanix Pharmaceuticals.

Summary

Botanix Pharmaceuticals beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

17031 (CNSX:MYM) and Botanix Pharmaceuticals (ASX:BOT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for 17031 and Botanix Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
170310000N/A
Botanix Pharmaceuticals0000N/A

Profitability

This table compares 17031 and Botanix Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
17031N/AN/AN/A
Botanix PharmaceuticalsN/AN/AN/A

Valuation & Earnings

This table compares 17031 and Botanix Pharmaceuticals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
17031N/AN/AN/AN/AN/A
Botanix Pharmaceuticals$6.89 million0.00$-9,731,420.16A($0.01)N/A

17031 has higher earnings, but lower revenue than Botanix Pharmaceuticals.

Summary

Botanix Pharmaceuticals beats 17031 on 1 of the 1 factors compared between the two stocks.


Botanix Pharmaceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena logo
ABZA
Abzena
0.6N/AN/A£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.61 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.57flat$0.00N/A0.00Gap Up
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
News Coverage
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.07flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00News Coverage
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.8N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BMEA
Biomea Fusion
0.0N/AN/A$0.00N/A0.00Upcoming Earnings
High Trading Volume
BNO
Bionomics
0.5N/AN/A$0.00$2.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.18 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$106,954.000.00High Trading Volume
News Coverage
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid
0.5N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.03flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
CHM
Chimeric Therapeutics
0.3N/AN/A$0.00N/A0.00High Trading Volume
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.32flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
CUV
Clinuvel Pharmaceuticals
1.0N/AN/A$0.00$38.34 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00
CSL logo
CSL
CSL
0.8N/AN/A$0.00$9.98 billion0.00High Trading Volume
Gap Up
Cybin logo
CLXPF
Cybin
1.0$1.40flat$0.00N/A0.00
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.59 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.12flat$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.